Route of administration and formulation dependent pharmacokinetics of 17-hydroxyprogesterone caproate in rats. [PDF]
Shaik IH +4 more
europepmc +1 more source
The association among cytochrome P450 3A, progesterone receptor polymorphisms, plasma 17-alpha hydroxyprogesterone caproate concentrations, and spontaneous preterm birth. [PDF]
Bustos ML +15 more
europepmc +1 more source
17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model. [PDF]
Amaral LM +5 more
europepmc +1 more source
17-Hydroxyprogesterone caproate in triplet pregnancy: an individual patient data meta-analysis. [PDF]
Combs CA +10 more
europepmc +1 more source
Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system. [PDF]
Manuck TA +4 more
europepmc +1 more source
Population pharmacokinetics of 17α-hydroxyprogesterone caproate in singleton gestation. [PDF]
Sharma S +6 more
europepmc +1 more source
Prevention of preterm labour: 2011 update on tocolysis. [PDF]
Hubinont C, Debieve F.
europepmc +1 more source
Cerclage for the prevention of preterm birth in high risk women receiving intramuscular 17-α-hydroxyprogesterone caproate. [PDF]
Szychowski JM +9 more
europepmc +1 more source

